Dr. Shihori Tanabe is a senior researcher at the Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences (NIHS), Japan. A part of her research is focused on molecular networks, gene expression profiling, and finding important factors in various cells, including cancer cells and stem cells, using a bioinformatics approach. She has been a delegate for the Japanese Society for Regenerative Medicine, a councilor for the Society for Regulatory Science of Medical Products, a councilor for the Japanese Society of Toxicology, a delegate for the Pharmaceutical Society of Japan, an international associate for the Japanese Pharmacological Society, and an editorial board member for several journals. She leads the Adverse Outcome Pathway (AOP) Coach Team and has been a co-lead of the External Review subgroup in OECD. She has published more than 100 papers, has organized several international conferences, and was awarded the Overseas Study Grant of the Foundation for Research on Metabolic Disorders in 2002 and a poster award at the 4th Technical Agora of Shimadzu in 2024.